---
figid: PMC4171341__nihms619456f2
figlink: /pmc/articles/PMC4171341/figure/F2/
number: F2
caption: A. Upon upstream activation, RAS becomes activated, resulting in signal transduction
  through RAF, MEK and ERK. The MAPK pathway can turn itself off via negative feedback
  loops at multiple nodes to prevent hyperactivity. Inhibitory function shown as red
  arrows; activating functions are shown as black arrows. B. Characterized oncogenic
  mutations in the MAPK pathway are shown in yellow. C. A simplified schema of adaptive
  MAPK signaling following pathway inhibition.
pmcid: PMC4171341
papertitle: 'Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer
  Cells.'
reftext: Vito W. Rebecca, et al. Biochem Pharmacol. ;91(4):417-425.
pmc_ranked_result_index: '2583'
pathway_score: 0.9474509
filename: nihms619456f2.jpg
figtitle: 'Change or Die: Targeting Adaptive Signaling to Kinase Inhibition in Cancer
  Cells'
year: ''
organisms: Homo sapiens
ndex: f538daf3-def1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4171341__nihms619456f2.html
  '@type': Dataset
  description: A. Upon upstream activation, RAS becomes activated, resulting in signal
    transduction through RAF, MEK and ERK. The MAPK pathway can turn itself off via
    negative feedback loops at multiple nodes to prevent hyperactivity. Inhibitory
    function shown as red arrows; activating functions are shown as black arrows.
    B. Characterized oncogenic mutations in the MAPK pathway are shown in yellow.
    C. A simplified schema of adaptive MAPK signaling following pathway inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXD3
  - RAF1
  - MAP2K1
  - MAPK1
  - BRAF
  - KRAS
  - NRAS
  - MAP2K2
  - MYC
  - HRAS
  - MAPK3
  - PEBP1
  - ARAF
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: FOXD3
  symbol: FOXD3
  source: hgnc_symbol
  hgnc_symbol: FOXD3
  entrez: '27022'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK2)
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: )MEK2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: ERK1
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (c-Myc
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: RKIP
  symbol: RKIP
  source: hgnc_alias_symbol
  hgnc_symbol: PEBP1
  entrez: '5037'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC4171341__F2
redirect_from: /figures/PMC4171341__F2
figtype: Figure
---
